{
  "q1": "HER-2/neu",
  "q2": "34/86",
  "q3": "The presence of gene amplification was correlated with estrogen receptor status and size of primary tumor (Table 2).",
  "q4": "While there was a somewhat shortened time to relapse and shorter overall survival in patients having any amplification of the HER-2/neu gene in their tumors (Fig.",
  "q5": "log rank test",
  "q6": "34/86",
  "q7": "Amplification of the HER-2/neu gene is a significant predictor ofboth overall survival and time to relapse in node-positive patients with breast cancer.",
  "q8": "47 months",
  "q9": "x2 test. P values werc computed after combining the 5 to 20 and >20 cases, since there - were so few samples in the >20 group. t Statistical analyses for correlation of HER-2/neu amplification with various disease parameters were performed by the x2 test. P values were computed after combining the cases with 5 to 20 and >20 copies.",
  "q10": "N-myc"
}